File Download

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Advances in MDS/AML and inositide signalling

Author(s)
De Stefano, AlessiaMarvi, Maria VittoriaFazio, AntoniettaMcCubrey, James A.Suh, Pann-GhillRatti, StefanoRamazzotti, GiuliaManzoli, LuciaCocco, LucioFollo, Matilde Y.
Issued Date
2023-01
DOI
10.1016/j.jbior.2023.100955
URI
https://scholarworks.unist.ac.kr/handle/201301/91490
Fulltext
https://www.sciencedirect.com/science/article/pii/S2212492623000015?pes=vor&utm_source=clarivate&getft_integrator=clarivate
Citation
ADVANCES IN BIOLOGICAL REGULATION, v.87, pp.100955
Abstract
Aberrant signaling pathways regulating proliferation and differentiation of hematopoietic stem cells (HSCs) can contribute to disease pathogenesis and neoplastic growth. Phosphoinositides (PIs) are inositol phospholipids that are implicated in the regulation of critical signaling pathways: aberrant regulation of Phospholipase C (PLC) beta1, PLCgamma1 and the PI3K/Akt/mTOR pathway play essential roles in the pathogenesis of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML).
Publisher
ELSEVIER
ISSN
2212-4926
Keyword (Author)
Myelodysplastic syndromesAcute myeloid leukemiaPI3KAktmTORInositidesSignalling

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.